Efficacy and Safety of Lactoferrin in Heart Failure Patients
A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 114 participants.
Also called NCT06427200
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 114 participants
- Sponsor
- Registry
-
NCT06427200
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT06427200. Randomized; no masking; primary purpose treatment. Start 2024-07 (anticipated); primary completion 2027-07 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Efficacy and Safety of Lactoferrin in Heart Failure Patients
- Intervention (Drug)
- oral Iron
- Intervention (Drug)
- Lactoferrin
- Intervention (Drug)
- lactoferrin and oral iron
- Lead sponsor
- Cairo University
Record details
- Record id
cardio:ct-nct06427200- Content hash
d38e07719e1a6c716b6dff5434b7f0acc91ead1f64ec74fe0d2ab2c7dd314fcb